Doxa AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0005624756
SEK
0.49
0 (0.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Doxa AB stock-summary
stock-summary
Doxa AB
Pharmaceuticals & Biotechnology
Doxa AB is a Sweden-based company which develops products based on bio-active ceramics. The Company develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
Company Coordinates stock-summary
Company Details
Axel Johanssons Gata 4-6 , UPPSALA None : 754 50
stock-summary
Tel: 46 18 4782000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Ms. Ingrid Atteryd Heiman
Chairman of the Board
Mr. Christian Lindgren
Director
Mr. Ljubo Mrnjavac
Director
Mr. Melker Nilsson
Director
Mr. Pal Ryfors
Director
Mr. Alexander Tasevski
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
9 Million
(Quarterly Results - Jun 2025)
Net Profit:
-81 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 694 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.60

stock-summary
Return on Equity

-24.95%

stock-summary
Price to Book

0.34